Stephen Gottschalk

Title: The Innovative Contributions of Stephen Gottschalk

Introduction

Stephen Gottschalk is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors. His work has the potential to advance cancer therapies and improve patient outcomes.

Latest Patents

Stephen Gottschalk holds a patent for "Chimeric antigen receptors with MYD88 and CD40 costimulatory domains." This patent relates to a chimeric antigen receptor that targets Eph receptors and facilitates the activation of co-stimulatory pathways. The application also encompasses polynucleotides that encode the chimeric antigen receptor, vectors, and host cells that incorporate this innovative receptor. Furthermore, it details methods for preparing host cells containing the chimeric antigen receptor to enhance their in vivo effector function. He has been granted 1 patent for this groundbreaking work.

Career Highlights

Throughout his career, Stephen Gottschalk has worked with prestigious institutions such as St. Jude Children's Research Hospital and Baylor College of Medicine. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Stephen has collaborated with notable colleagues, including Brooke Prinzing and Giedre Krenciute. Their combined expertise has fostered an environment of innovation and discovery in the realm of chimeric antigen receptor technology.

Conclusion

Stephen Gottschalk's contributions to the field of biomedical engineering, particularly through his patent on chimeric antigen receptors, highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and patient care.